The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 127:462-471, October 1970
doi: 10.1176/appi.ajp.127.4.462
© 1970 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by ITIL, T. M.
* Articles by KLINGENBERG, H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by ITIL, T. M.
* Articles by KLINGENBERG, H.

Digital Computer Analyzed Sleep and Resting EEG During Haloperidol Treatment

TURAN M. ITIL M.D.1, PATRICK GANNON M.D.2, WILLIAM HSU M.S.3, , and HELEN KLINGENBERG 4

1 Professor and associate chairman, and director, section of psychopharmacology, department of psychiatry, University of Missouri School of Medicine, Missouri Institute of Psychiatry, 5400 Arsenal St., St. Louis, Mo. 63139
2 Instructor of psychiatry, department of psychiatry, University of Missouri School of Medicine, Missouri Institute of Psychiatry, 5400 Arsenal St., St. Louis, Mo. 63139
3 System analyst and statistician, department of psychiatry, University of Missouri School of Medicine, Missouri Institute of Psychiatry, 5400 Arsenal St., St. Louis, Mo. 63139
4 Chief EEG technologist in the sleep lab, department of psychiatry, University of Missouri School of Medicine, Missouri Institute of Psychiatry, 5400 Arsenal St., St. Louis, Mo. 63139

The authors studied the effects of haloperidol on resting and all-night sleep EEGs of chronic schizophrenic patients. There was a decrease in slow waves and an increase in fast activity during resting and sleep EEGs as well as a decrease in the time spent in deep sleep stages during sleep. The findings support the hypothesis that compounds that are most effective with chronic schizophrenic patients have both central inhibitory and stimulating components.







Get information about faster international access.

Privacy Policy

Copyright © 1970 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org